Language selection

Search

Patent 2580752 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2580752
(54) English Title: VASCULAR OCCLUSION DEVICE WITH AN EMBOLIC MESH RIBBON
(54) French Title: DISPOSITIF D'OCCLUSION VASCULAIRE A RUBAN D'EMBOLISATION EN TREILLIS
Status: Deemed Expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61B 17/08 (2006.01)
(72) Inventors :
  • JONES, DONALD K. (United States of America)
  • SLAZAS, ROBERT R. (United States of America)
  • FELLER, FREDERICK III (United States of America)
(73) Owners :
  • CORDIS NEUROVASCULAR, INC.
(71) Applicants :
  • CORDIS NEUROVASCULAR, INC. (United States of America)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued: 2014-11-25
(86) PCT Filing Date: 2005-09-16
(87) Open to Public Inspection: 2006-03-30
Examination requested: 2010-09-01
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2005/033399
(87) International Publication Number: US2005033399
(85) National Entry: 2007-03-16

(30) Application Priority Data:
Application No. Country/Territory Date
60/610,780 (United States of America) 2004-09-17

Abstracts

English Abstract


A vascular occlusion device that includes a central support member that has at
least one mesh embolic ribbon extending outwardly from the central support
member in the generally radial direction is provided. The mesh embolic ribbon
has a collapsed and an expanded configuration.


French Abstract

L'invention concerne un dispositif d'occlusion vasculaire comprenant un élément de support central équipé d'au moins un ruban d'embolisation à treillis s'étendant vers l'extérieur à partir de l'élément de support central dans un sens généralement radial. Ledit ruban d'embolisation à treillis possède une configuration affaissée et déployée.

Claims

Note: Claims are shown in the official language in which they were submitted.


17
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An occlusion device comprising:
a central support member having a length and a cross-
sectional width, the central support member is wound into a
helically shaped coil; and
at least one embolic ribbon extending from the central
support member in a generally radial direction, said at least
one embolic ribbon also extending at least partially along
the length of the central support member, wherein the at
least one embolic ribbon is shaped into a spiral pattern
around the central support member.
2. The occlusion device of claim 1 wherein the central
support member comprises a wire.
3. The occlusion device of claim 1 wherein the central
support member comprises a hollow tubular structure.
4. The occlusion device of claim 1 wherein the central
support member is integral with the at least one embolic
ribbon.
5. The occlusion device of claim 1 wherein the cross-
sectional width of the central support member comprises a
diameter.
6. The occlusion device of claim 1 wherein the at least
one embolic ribbon is comprised of a metal.
7. The occlusion device of claim 6 wherein the metal is a
shape memory alloy.
8. The occlusion device of claim 1 wherein the at least
one embolic ribbon comprises a mesh.
9. The occlusion device of claim 8 wherein the at least
one embolic ribbon comprises a substrate, and the mesh is

18
formed by a plurality of apertures extending through the
substrate.
10. The occlusion device of claim 8 wherein the mesh is
formed from a braided element.
11. The occlusion device of claim 1 wherein the at least
one embolic ribbon has a collapsed state and an expanded
state.
12. The occlusion device of claim 11 wherein a
transformation between the collapsed state and the expanded
state is temperature activated.
13. The occlusion device of claim 12 wherein the
transformation between the collapsed state and the expanded
state is activated at approximately body temperature.
14. The occlusion device of claim 1 wherein the at least
one embolic ribbon comprises a pair of opposed embolic
ribbons.
15. A vascular occlusion device, comprising:
an embolic coil formed from a support wire of a
selected length wound into a helical shape; and
a pair of opposed mesh embolic ribbons located on the
support wire, said pair of mesh embolic ribbons extending
along at least a portion of the length of the support wire
and extending outwardly from the support wire, wherein the
mesh embolic ribbons are shaped into a spiral around the
support wire.
16. The vascular occlusion device of claim 15 wherein the
pair of opposed mesh embolic ribbons comprise a metal.
17. The vascular occlusion device of claim 16 wherein the
metal is a shape memory metal.

19
18. The vascular occlusion device of claim 15 wherein each
of the opposed mesh embolic ribbons comprises a substrate
with apertures extending therethrough.
19. The vascular occlusion device of claim 15 wherein each
of the opposed mesh embolic ribbons comprises a braided
element.
20. The vascular occlusion device of claim 15 wherein each
of the opposed mesh embolic ribbons includes a collapsed
state and an expanded state.
21. The vascular occlusion device of claim 15 wherein at
least one of the opposed mesh embolic ribbons has a thickness
greater than about 0.1 microns but less than about 5 microns.
22. An occlusion device, comprising:
an embolic mesh ribbon, said ribbon twisted into a
spiral-like pattern as a spiraled ribbon length; and
said spiraled ribbon length is helically coiled into
the occlusion device.
23. The occlusion device of claim 22 wherein the ribbon
comprises a metal.
24. The occlusion device of claim 23 wherein the metal is a
shape memory alloy.
25. The occlusion device of claim 23 wherein the shape
memory alloy is a nitinol.
26. A method of making an occlusion device, comprising;
winding a support wire around a mandrel in a helical
fashion to form adjacent coils;
coating the support wire and the mandrel with a thin
metal film;
cutting the thin metal film between the adjacent coils
to create at least one embolic ribbon extending from the
support wire;

20
perforating the pair of opposed embolic ribbons;
separating the support wire and thin metal film from
the mandrel;
twisting the support wire relative to the longitudinal
axis to form the at least one embolic ribbon into a spiral
shape; and
winding the support wire into a helical shape.
27. The method according to claim 26 wherein the winding
comprises winding the support wire around a copper mandrel
and the separating comprises dissolving the copper mandrel in
acid.
28. The method according to claim 26 wherein the separating
comprises dissolving the mandrel away.
29. The method according to claim 26 wherein the shaping
includes uncoiling the support wire by stretching the support
wire along a longitudinal axis of the support wire.
30. The method according to claim 26 wherein the coating
comprises coating the mandrel and the support wire with a
thin shape memory alloy film; and
further including heat-treating the thin shape memory-
alloy film at said desired shape.
31. The method according to claim 26 wherein the coating
comprises sputtering and depositing a thin metal film.
32. The method according to claim 26 wherein the cutting
comprises cutting the thin metal film between the adjacent
coils to create a pair of opposed embolic ribbons.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02580752 2014-01-31
1
VASCULAR OCCLUSION DEVICE
WITH AN EMBOLIC MESH RIBBON
[001]
Field of the Invention
[002] The present invention generally relates to medical
devices and methods which are used to occlude vessels within a
patient, and more particularly, to occlusion devices which
include an embolic mesh ribbon.
Background of the Invention
[003] An aneurysm is an abnormal bulge or ballooning of
the wall of a blood vessel. Typically, an aneurysm develops in
a weakened wall of an arterial blood vessel. The force of the
blood pressure against the weakened wall causes the wall to
abnormally bulge or balloon outwardly. One detrimental effect
of an aneurysm is that the aneurysm may apply undesired
pressure to tissue surrounding the blood vessel. This
pressure can be extremely problematic especially in the case
of a cranial aneurysm where the aneurysm can apply pressure
against sensitive brain tissue. Additionally, there is also
the possibility that the aneurysm may rupture or burst leading
to more serious medical complications including mortality.
[004] When a patient is diagnosed with an unruptured
aneurysm, the aneurysm is treated in an attempt to reduce or
lessen the bulging and to prevent the aneurysm from rupturing.

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
2
Unruptured aneurysms have traditionally been treated by what
is commonly known in the art as "clipping." Clipping requires
an invasive surgical procedure wherein the surgeon makes
incisions into the patient's body to access the blood vessel
containing an aneurysm. Once the surgeon has accessed the
aneurysm, he or she places a clip around the neck of the
aneurysm to block the flow of blood into the aneurysm which
prevents the aneurysm from rupturing. While clipping may be
an acceptable treatment for some aneurysms, there is a
considerable amount of risk involved with employing the
clipping procedure to treat cranial aneurysms because such
procedures require open brain surgery.
[005] More recently, intravascular catheter techniques
have been used to treat cranial aneurysms because such
techniques do not require cranial or skull incisions, i.e.,
these techniques do not require open brain surgery. Typically,
these techniques involve using a catheter to deliver embolic
devices to a preselected location within the vasculature of a
patient. For example, in the case of a cranial aneurysm,
methods and procedures, which are well known in the art, are
used for inserting and guiding the distal end of a delivery
catheter into the vasculature of a patient to the site of the
cranial aneurysm. A vascular occlusion device is then
attached to the end of a pusher member which pushes the
occlusion device through the catheter and out of the distal
end of the catheter where the occlusion device is delivered
into the aneurysm.
[006] Once the occlusion device has been deployed within
the aneurysm, the blood clots on the occlusion device and
forms a thrombus. The thrombus forms an occlusion which seals
off the aneurysm, preventing further ballooning or rupture.
The deployment procedure is repeated until the desired number
of occlusion devices are deployed within the aneurysm.
Typically, it is desired to deploy enough coils to obtain a

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
3
packing density of about 20% or more, preferably about 35% and
more if possible.
[007] The most common vascular occlusion device is an
embolic coil. Embolic coils are typically constructed from a
metal wire which has been wound into a helical shape. One of
the drawbacks of embolic coils is that they do not provide a
large surface area for blood to clot thereto. Additionally,
the embolic coil may be situated in such a way that there are
relatively considerable gaps between adjacent coils in which
blood may freely flow. The addition of extra coils into the
aneurysm does not always solve this problem because deploying
too many coils into the aneurysm may lead to an undesired
rupture.
[008] Therefore, there remains a need that is recognized
and addressed according to the present invention for an
occlusion device which provides a greater surface area to
promote the clotting of blood, and also effectively occupies
the space between adjacent occlusion devices without
increasing the risk of rupturing the aneurysm.
Summary of the Invention
[009] The present invention generally relates to vascular
occlusion devices and methods for making and using the same.
The vascular occlusion devices of the present invention may be
associated with a standard delivery catheter system and
deployed to a preselected site within the vasculature of a
patient using techniques and professional methods generally
known in the art.
[0010] In one preferred embodiment of the present
invention, the vascular occlusion device includes a support
wire which has been formed into a helical shape, for example
the shape of a standard embolic coil. The occlusion device
also includes at least one mesh embolic ribbon, and more
preferably a pair of opposed thin mesh embolic ribbons. The

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
4
embolic ribbons extend outwardly from the support wire in a
generally radial direction, and are preferably twisted into a
spiral pattern along the length of the support wire.
[0011] In another preferred embodiment of the present
invention, the occlusion device comprises a hollow tubular
central support element which includes a pair of thin mesh
embolic ribbons extending from the tubular support element in
a generally radial direction. Preferably, the tubular support
element and the mesh ribbon material are a unitary structure.
In yet another preferred embodiment, a central support element
is not required, and the thin mesh ribbon material can be
self-supporting. In this embodiment, the occlusion device
comprises a mesh ribbon which is preferably twisted into a
corkscrew-like or spiral configuration, and then wound into a
helical coil.
[0012] The occlusive devices of the present invention can
be made by winding a support wire around a cylindrical mandrel
having semicircular shaped grooves into which the support wire
nests. Deposition techniques that are generally known in the
art are employed to coat the mandrel and support wire with a
thin metal film, such as a nickel-titanium alloy, specifically
a nitinol. The thin metal film is then separated, such as by
laser-cutting, to form a pair of metal mesh ribbons. The
mandrel is removed, and the support wire is stretched in the
longitudinal direction to uncoil the support wire. Next, the
support wire is twisted about the longitudinal axis of the
support wire to form the mesh ribbons into a spiral pattern.
The support wire is then formed into the desired shape,
preferably a helically wound coil.
[0013] Therefore, it is an object or aspect of the present
invention to provide a vascular occlusion device that provides
a large surface area for the promotion of blood clotting.

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
[0014] It is also an object or aspect of the present
invention to provide methods of making an occlusion device
having mesh embolic ribbons.
[0015] Other aspects, objects and advantages of the present
invention will be understood from the following description
according to the preferred embodiments of the present
invention, specifically including stated and unstated
combinations of the various features which are described
herein, relevant information concerning which is shown in the
accompanying drawing.
Brief Description of the Drawings
[0016] In describing the preferred embodiments of the
present invention, reference will be made to the accompanying
drawings, wherein:
[0017] FIG. 1 is a perspective view of a preferred
embodiment of the occlusion device of the present invention;
[0018] FIG. 2 is an enlarged partially sectioned view of an
embodiment of the occlusion device having a support wire;
[0019] FIG. 3 is an enlarged partially sectioned view of
another embodiment of the occlusion device of the present
invention;
[0020] FIG. 4 is an enlarged partially sectioned view of
yet another embodiment of the occlusion device of the present
invention.
[0021] FIG. 5 is a perspective view of a mandrel which can
be used in a method to make occlusion devices of the present
invention;
[0022] FIG. 6 is a partial cross-section view of the
mandrel of Fig. 5 shown with a support wire and a coating of
metal film;
[0023] FIG. 7 is a partial cross-sectional view of the
mandrel of Fig. 5 shown with a base wire wound around the
mandrel and a first and second layer of thin metal film;

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
6
[ 0 024 ] FIG. 8 is an enlarged partial side view of an
occlusion device of the present invention prior to being
twisted and helically wound;
[0025] FIG. 9 is a perspective view of a mandrel coated
with a thin film as a step in making devices according to an
embodiment as illustrated in Fig. 4;
[0026] FIG. 10 is a perspective view of the mandrel of Fig.
9 after the thin film has been severed in a subsequent step;
[0027] FIG. 11 is a perspective view of the mandrel of Fig.
after the thin film has been perforated to form a mesh; and
[0028] FIG. 12 is a perspective view of the ribbon before
the ribbon is shaped into the desired configuration.
Description of the Preferred Embodiments
[0029] As required, detailed embodiments of the present
invention are disclosed herein; however, it is to be
understood that the disclosed embodiments are merely exemplary
of the invention, which may be embodied in various forms.
Therefore, specific details disclosed herein are not to be
interpreted as limiting, but merely as a basis for the claims
and as a representative basis for teaching one skilled in the
art to variously employ the present invention in virtually any
appropriate manner.
[0030] The occlusion devices of the present invention are
generally designed to be delivered to a preselected site
within a vessel of a patient by using standard deployment
systems, such as TRUFILL DCS ORBITTm (Cordis Corporation)
hydraulic detachable coils deployment systems, other
mechanical, electrolytic or thermal systems or the like, or
any other deployment systems or techniques that may be
developed in the future. For convenience and simplicity, the
following description of the present invention will be
described in terms of a vascular occlusion device. However, it
will be understood that the description herein should not be

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
7
considered to limit the invention to only en.dovascular
procedures.
[0031] Fig. 1 generally illustrates a preferred embodiment
of the vascular occlusion device of the present invention.
The vascular occlusion device, generally designated at 10, is
preferably helically shaped to form coils 12. As illustrated
in Fig. 2, in one embodiment, the occlusion device 10a
includes a center support element, illustrated as a support
wire 14. A first embolic mesh ribbon 16 and a second embolic
mesh ribbon 18 are located on the support wire 14 and extend
from the support wire in a generally radial direction. The
mesh ribbons 16, 18 may be deposited on the support wire 14,
as in the method described below, or may be attached by a
biocompatible adhesive, weld or solder. The first embolic
mesh ribbon 16 and the second embolic mesh ribbon 18 may be
configured into any simple or complex shape, and are
preferably twisted into a spiral pattern around the support
wire 14. In an alternative embodiment, the occlusion device
may include only one embolic ribbon located on the center
support element.
[0032] The support wire 14 preferably comprises a metal,
and has a diameter between about .0005 inch (about 0.013 mm)
and about 0.004 inch (about 0.1 mm). The support wire is
preferably wound into a helical shape having an overall
diameter of between about 0.005 inch (about 0.13 mm) and about
0.015 inch (about 0.38 mm). Suitable metals for the support
wire include, but are not limited to, stainless steel,
platinum, gold or nitinol. The wire may be configured into a
variety of different shapes, such as helical coils, spheres,
ellipses, spirals, complex curves or the like. Preferably,
the wire is configured into a helical coil. When the support
wire is made from a nitinol or other shape memory alloy, the
support wire may transition between a martensitic state and an

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
8
austenitic state, and may be heat treated into any variety of
desired shapes, as mentioned above.
[0033] More preferably, the support wire is comprised of a
radiopaque material to aid in the accurate placement of the
occlusion device 10a within the vasculature of a patient.
Such radiopaque material may include platinum, tungsten or
gold. The material of the support wire 14 may also be any
other suitable material, such as a thin polymer wire or tube.
Radiopaque material can be included in the form of a ring or
rings of any useful shape.
[0034] The first and second embolic mesh ribbons 16, 18 are
preferably comprised of a thin metal film having apertures 20
extending through the film. The mesh may also be a braided
mesh which is formed from a multifilament braid. Preferably,
the size of the apertures 20 is between about 5 microns and
about 100 microns, and more preferrably between about 10
microns and about 50 microns. The thickness of each embolic
ribbon 16, 18 may range from about 5 to about 250 microns, and
is preferably between about 10 microns and about 20 microns.
When the embolic ribbons are comprised of a thin film
material, such as a thin film of nitinol, the thickness of the
thin film is preferably between about 0.1 and 250 microns and
typically between about 1 and 30 microns. More preferably,
the thickness of the thin film is between about 1 to 10
microns or at least about 0.1 microns but less than about 5
microns. The width extending from the outer edge 15 of the
first ribbon 16 to the outer edge 17 of the second ribbon 18
is preferably between about 0.012 inch (about 0.3 mm) and
about .015 inch (about 0.38 mm) in the spiraled shape. In
general, the sizing of the device can be varied as needed to
be properly accommodated by catheters or devices by which they
can be delivered.
[0035] In one embodiment, the embolic mesh ribbons 16, 18
are comprised of metal having shape memory and super

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
9
elasticity such as a nickel-titanium alloy, and more
specifically a nitinol. However, as may be appreciated, the
embolic mesh ribbons may also be fabricated from any other
suitable metal, such as stainless steel, platinum, tungsten or
the like, or any suitable biocompatible material, such as a
polymer.
[0036] Preferably, the embolic mesh ribbons may be
transformed between a collapsed state and an expanded state.
Such transformable feature is especially advantageous when the
embolic mesh ribbons 16, 18 are fabricated from nitinol, or
any other suitable shape memory material. In the collapsed
state the embolic ribbons 16, 18 may be collapsed inward
toward the support wire, so as to lessen the overall cross-
sectional width (diameter for circular configurations) of the
occlusion device 10. In the expanded state (which can be seen
in Fig. 2), the embolic ribbons 16, 18 may extend outwardly
from the support wire in a generally radial direction,
expanding the overall cross-sectional width of the occlusion
device 10 and increasing the overall surface area available
for blood to clot thereto.
[0037] In this embodiment, the width of each of the embolic
ribbons may be any size as long as the overall size of the
occlusion device is sized to fit within the desired sized
delivery catheter when the ribbons are in the collapsed state.
The transition between the collapsed state and the expanded
state is preferably temperature activated, and the ribbon
preferably transitions between the collapsed state and the
expanded state between a temperature of about 30 degrees C.
and about 40 degrees C., and more preferably at about the
patient's body temperature during the procedure.
[0038] When the ribbons are comprised of nitinol, the
ribbons may be martensite, or the ribbons may be austenite
with a transition from martensite to austenite. If the
ribbons are designed to remain martensitic, the configuration

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
of the ribbon in the martensitic state is preferably the
expanded position, as illustrated in Fig. 2. Alternatively,
the configuration of the ribbons in the martensitic state can
be any desired configuration, depending on the intended use.
If the ribbons are designed to transition between the
martensitic state and the austenitic state, the ribbons may be
heat treated so that the ribbons are in the expanded state
while austenitic. Alternatively, the ribbons may be heat
treated to form any other desired simple or complex austenitic
state configuration. While martensitic, the ribbons may be of
any configuration, and preferrably are collapsed inward toward
the support element.
[0039] Fig. 3 illustrates another preferred embodiment of
the occlusion device of the present invention. In this
embodiment, the occlusion device 10b includes a central
tubular support element 24 having a hollow inner channel 26
which may extend through the entire length of the tubular
support element 24. A pair of opposed embolic mesh ribbons
16b, 18b, which are of the generally same construction as
described above, extend outwardly from the tubular support
element 24 in a generally radial direction. The tubular
support element 24 and the mesh ribbons 16b and 18b are
preferably of a unitary structure. However, it is contemplated
that the tubular support element 24 and the embolic ribbons
16b, 18b may be of different structures that are attached
together by any suitable attachment means, such as by a
biocompatible adhesive, weld or solder.
[0040] A support wire 28, similar to support wire 12, may
be inserted into the channel 26 of the tubular support member
24 to strengthen the structure of the occlusion device 10b.
This embodiment provides for various processing options. For
example, the ribbons and the support wire may be heat treated
separately, typically before the support wire 28 is inserted
into the channel 26. Each then can have different properties

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
11
due to their respective different materials and/or due to heat
treatment differences. This can be especially beneficial when
the ribbons 16b, 18b and the support wire 28 are made of
nitinol and are in different states due to heat treatment
variations.
[0041] Yet another embodiment of the vascular occlusion
device of the present invention is illustrated in Fig. 4. In
this embodiment, the occlusion device 10c comprises a mesh
ribbon material 29 that is self-supporting, eliminating the
need for a central support element. The mesh ribbon 29 may be
made of any of materials as described above with respect to
mesh ribbons 16, 18. The mesh ribbon 29 is preferably twisted
to form a spiral or cork-screw-like configuration, and then
wound into a helical shape, as illustrated in Fig. 1.
Alternatively, the mesh ribbon 29 may be shaped into any
desired simple or complex configuration. When the occlusion
device 10c is comprised of a nitinol, it may be designed to
remain in a martensitic state, or it may be designed so that
it transitions between a martensitic and an austenitic state.
[0042] In addition to the features described herein, the
vascular occlusion devices of the present invention may also
include one or more bioactive materials, such as fibrous
materials, foam materials, coatings, therapeutic agents,
thrombogenic agents, non-thrombogenic agents, growth factors
and the like. Additionally, the occlusion devices of the
present invention may also include an attachment location for
releasably attaching to a deployment system, such as an
attachment head 21 located at the end of support wire 14, as
illustrated in Fig. 2.
[0043] The occlusion devices described herein are designed
to be deployed to a preselected site within a vessel of the
body. In treating an aneurysm, a delivery catheter is guided
through the vasculature system of a patient to the site of an
aneurysm using standard techniques and professional methods

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
12
generally known in the art. When the ribbons have the feature
of being transitioned between a collapsed state and an
expanded state, the vascular occlusion device is releasably
attached to the distal end of a pusher element with the
ribbons in the collapsed state. The pusher element pushes and
guides the vascular occlusion device through the delivery
catheter to the site of the aneurysm. The vascular occlusion
device is guided out of the distal end of the delivery
catheter into the aneurysm. The vascular occlusion device is
released from the distal end of the pusher. Once inside the
aneurysm, the vascular occlusion device may take the form of a
variety of simple and complex shapes and configurations, and
the mesh embolic ribbons transition into the expanded state.
The mesh embolic ribbons increase the amount of space the
vascular occlusion device occupies, and thereby increases the
surface area onto which the blood can clot and form a
thrombus.
[0044] This method may be repeated until the desired number
of occlusion devices are deployed within the aneurysm. The
expanded mesh ribbons fill the space within the aneurysm, and
the mesh ribbons are preferably flexible and elastic so that
the mesh ribbons may yield to pressure from surrounding
occlusion devices and/or the wall of the vessel. The flexible
and elastic characteristics of the mesh ribbons allow the mesh
ribbons to fill in the space between adjacent occlusion
devices without creating a high-pressure situation, and thus
reducing the risk of a rupture.
[0045] The occlusion devices of the present invention may
be made by many different methods. The following method can
be used to make an embodiment of the present invention. As
illustrated in Fig. 5, a mandrel or core 32 may be provided
with a semicircular spiral groove 34. As illustrated in Fig.
6, a support wire 14 is wound around the mandrel 32 creating
adjacent coils 35. The support wire 14 is wound so that the

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
13
support wire nests within the grooves 34, leaving about half
of the exterior surface of the support wire 14 exposed. The
mandrel 32 and the support wire 14 are then coated with a thin
film of metal 36 preferably by using deposition and sputtering
devices and techniques which are generally known in the art.
The thin metal film 36 is preferably a nickel-titanium metal
alloy, such as a nitinol. Alternatively, the thin metal film
may be any other suitable metal, such as stainless steel,
platinum, tungsten or the like.
[0046] After the mandrel 32 and support wire 14 have been
coated with the thin metal film 36, the thin metal film 36 is
then cut with a laser or mechanical means or conventional
process between adjacent coils 35 at lines 38 to create a pair
of opposed ribbons. The thin metal film may be cut at a
location equidistant between the adjacent coils 35 to create
ribbons of substantially the same width. Alternatively, the
thin metal film may be cut closer to one coil to create
ribbons of different size width. If only a single ribbon is
desired, the thin metal film may be cut at a location adjacent
to one of the coils, as illustrated at cut lines 41. Next,
the thin metal film 36 is perforated by a laser or mechanical
means or conventional process to form a mesh.
[0047] Once the thin metal film 36 has been cut and
perforated or otherwise formed into a mesh material, the
mandrel 32 is removed. The mandrel 32 is preferably made of
copper and is removed by dissolving the copper mandrel in
acid. However, the mandrel 32 may be made of any suitable
material and may be removed by any suitable method generally
known in the art. It is preferred that the mandrel 32 be
removed after the thin film 36 has been cut and perforated.
However, it will be understood that the order of performance
of cutting the thin film, perforating the thin film and
removing the mandrel may occur in any desired order.

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
14
[ 0 048 ] After the mandrel 32 has been removed, such as by
dissolving, the support wire 14 is stretched axially into the
shape shown in Fig. 8. The support wire 14 is then twisted
relative to the longitudinal axis of the support wire, as
indicated at 39 in Fig. 7, to form the ribbons 16, 18 into a
spiral pattern.
[0049] If the ribbons 16, 18 are made of a thermal shape
memory alloy, such as a nitinol, the ribbons may now be heat
treated to set the desired shape. The support wire 14 is then
wound, preferably onto a mandrel (not shown), to shape the
support wire into a helix, as generally illustrated in Fig. 1.
Alternatively, the support wire 14 may be configured into any
simple or complex configuration.
[0050] In another method which may be followed for making
occlusion devices of the present invention, referring to Fig.
7, the mandrel 32 is coated with a first thin metal film 44
preferably by employing sputtering and deposition techniques
and devices that are generally known in the art. The first
thin metal may be comprised of any of the above mentioned
suitable metals. A base wire 46 is wound around the coated
mandrel 32 so that the base wire nests within grooves 34
having the metal film coating 44. A second layer of thin
metal film 48, which may comprise a material different from or
the same as the first thin metal film 44, is coated onto the
first layer of thin metal film 44 and the base wire 46 where
wire 46 is positioned over the film 44.
[0051] Both the first and second layers of thin metal film
44, 48 are cut along lines 50 to form a pair of ribbons.
Alternatively, the film can be severed to form a single
ribbon, in substantially the same manner as described above.
The ribbons or ribbon may then be perforated in substantially
the same manner as described above.
[0052] The mandrel 32 and the base wire 46 are then removed
from the assembly. Preferably, the mandrel 40 and the base

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
wire 46 are comprised of copper and are removed by dissolving
the base wire and the mandrel in an acid. However, the
mandrel 32 and the base wire 46 may be made of any suitable
material and may be removed by any suitable method generally
known in the art.
[0053] Dissolving the base wire 46 creates a center support
tube with a lumen extending the length of the support tube
similar to the device shown in Fig. 3. The occlusion device
is now stretched and twisted relative to the longitudinal axis
of the support tube to form the ribbons into a spiral pattern.
At this point, if desired, the structure of the occlusion
device may be strengthened by inserting a support wire into
the lumen and attaching the support wire to the support tube.
If the wire is made of a shape memory alloy, such as a
nitinol, the wire may be heat treated to set the desired
configuration before being inserted into the support tube.
Alternatively, the wire and the ribbon material may be heat
treated together. The occlusion device may now be configured
into the desired shape. Preferably, the occlusion device is
wound around a mandrel (not shown) to shape the occlusion
device into a helical coil, as shown in Fig. 1.
[0054] In yet another method of making the occlusive device
of the present invention, referring to Fig. 9, a mandrel 54 is
coated with a thin film 56 preferably by employing sputtering
and deposition techniques and devices known in the art. The
thin metal may be comprised of any of the above mentioned
suitable metals. Referring to Fig. 10, the thin film 56 is
then cut along lines 58, in substantially the same manner as
described above, to form a ribbon 57 that is coiled around the
mandrel and has adjacent coils 59. The ribbon 57 is then
perforated, in substantially the same manner as described
above, to form a mesh having slots or apertures 20, as
illustrated in Fig. 11.

CA 02580752 2007-03-16
WO 2006/034150
PCT/US2005/033399
16
[0055] The mandrel 54 then is separated from the ribbon 57
in any suitable manner. Preferably, the mandrel 54 is made of
copper and is separated from the ribbon 57 by dissolving the
mandrel in acid. The ribbon 57 is stretched axially into the
shape illustrated in Fig. 12. If the ribbon is made from a
shape-memory alloy metal, such as a nitinol, the ribbon may be
shaped into the desired configuration and heat treated.
Preferably, the ribbon is twisted, as generally designated at
60, to form a spiral pattern as illustrated in Fig. 4, and
wound into a coil, as illustrated in Fig. 1, or otherwise
formed into a desired shape of the occlusion device or the
like.
[0056] It will be understood that the embodiments of the
present invention which have been described are illustrative
of some of the applications of the principles of the present
invention. Numerous modifications may be made by those
skilled in the art without departing from the true spirit and
scope of the invention, including those combinations of
features that are individually disclosed or claimed herein.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Letter Sent 2024-03-18
Letter Sent 2023-09-18
Common Representative Appointed 2019-10-30
Common Representative Appointed 2019-10-30
Grant by Issuance 2014-11-25
Inactive: Cover page published 2014-11-24
Pre-grant 2014-09-12
Inactive: Final fee received 2014-09-12
Notice of Allowance is Issued 2014-03-12
Letter Sent 2014-03-12
4 2014-03-12
Notice of Allowance is Issued 2014-03-12
Inactive: Q2 passed 2014-03-10
Inactive: Approved for allowance (AFA) 2014-03-10
Letter Sent 2014-02-06
Reinstatement Request Received 2014-01-31
Amendment Received - Voluntary Amendment 2014-01-31
Reinstatement Requirements Deemed Compliant for All Abandonment Reasons 2014-01-31
Inactive: Abandoned - No reply to s.30(2) Rules requisition 2013-01-31
Inactive: S.30(2) Rules - Examiner requisition 2012-07-31
Letter Sent 2010-09-13
Request for Examination Received 2010-09-01
Request for Examination Requirements Determined Compliant 2010-09-01
All Requirements for Examination Determined Compliant 2010-09-01
Inactive: Delete abandonment 2008-05-05
Letter Sent 2008-03-25
Inactive: Abandoned - No reply to Office letter 2008-02-05
Inactive: Single transfer 2008-01-10
Inactive: Office letter 2007-11-05
Inactive: Single transfer 2007-09-10
Inactive: Cover page published 2007-05-29
Inactive: Courtesy letter - Evidence 2007-05-15
Inactive: Notice - National entry - No RFE 2007-05-11
Application Received - PCT 2007-04-10
National Entry Requirements Determined Compliant 2007-03-16
Application Published (Open to Public Inspection) 2006-03-30

Abandonment History

Abandonment Date Reason Reinstatement Date
2014-01-31

Maintenance Fee

The last payment was received on 2014-08-26

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
CORDIS NEUROVASCULAR, INC.
Past Owners on Record
DONALD K. JONES
FREDERICK III FELLER
ROBERT R. SLAZAS
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2007-03-15 16 750
Claims 2007-03-15 6 180
Abstract 2007-03-15 1 65
Drawings 2007-03-15 3 102
Representative drawing 2007-05-27 1 15
Cover Page 2007-05-28 1 42
Claims 2014-01-30 4 128
Description 2014-01-30 16 744
Cover Page 2014-10-23 1 43
Notice of National Entry 2007-05-10 1 192
Courtesy - Certificate of registration (related document(s)) 2008-03-24 1 105
Reminder - Request for Examination 2010-05-17 1 129
Acknowledgement of Request for Examination 2010-09-12 1 179
Courtesy - Abandonment Letter (R30(2)) 2013-03-27 1 165
Courtesy - Patent Term Deemed Expired 2024-04-28 1 555
Notice of Reinstatement 2014-02-05 1 169
Commissioner's Notice - Application Found Allowable 2014-03-11 1 162
Commissioner's Notice - Maintenance Fee for a Patent Not Paid 2023-10-29 1 551
PCT 2007-03-15 1 44
Correspondence 2007-05-10 1 27
Correspondence 2007-11-04 1 23
PCT 2008-02-19 2 97
PCT 2010-07-18 2 105
Correspondence 2014-09-11 1 59